<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">RSC Adv</journal-id><journal-id journal-id-type="iso-abbrev">RSC Adv</journal-id><journal-id journal-id-type="publisher-id">RA</journal-id><journal-id journal-id-type="coden">RSCACL</journal-id><journal-title-group><journal-title>RSC Advances</journal-title></journal-title-group><issn pub-type="epub">2046-2069</issn><publisher><publisher-name>The Royal Society of Chemistry</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400506</article-id><article-id pub-id-type="pmc">PMC12094013</article-id><article-id pub-id-type="publisher-id">d5ra01633a</article-id><article-id pub-id-type="doi">10.1039/d5ra01633a</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>Enantioselective synthesis of spiro[indoline-3,1&#x02032;-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] derivatives <italic toggle="yes">via</italic> an organocatalytic three-component cascade reaction<xref rid="fn1" ref-type="fn">&#x02020;</xref></article-title><fn-group><fn id="fn1"><label>&#x02020;</label><p>Electronic supplementary information (ESI) available. CCDC <uri>2384066</uri>. For ESI and crystallographic data in CIF or other electronic format see DOI: <uri xlink:href="https://doi.org/10.1039/d5ra01633a">https://doi.org/10.1039/d5ra01633a</uri></p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Song</surname><given-names>Luying</given-names></name><xref rid="affa" ref-type="aff">a</xref><xref rid="affb" ref-type="aff">b</xref><xref rid="fn2" ref-type="author-notes">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Yuhong</given-names></name><xref rid="affa" ref-type="aff">a</xref><xref rid="affb" ref-type="aff">b</xref><xref rid="fn2" ref-type="author-notes">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>An</surname><given-names>Renbo</given-names></name><xref rid="affb" ref-type="aff">b</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Liming</given-names></name><xref rid="affa" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1518-1601</contrib-id><name><surname>Jin</surname><given-names>Ying</given-names></name><xref rid="affa" ref-type="aff">a</xref><xref rid="affb" ref-type="aff">b</xref></contrib><aff id="affa">
<label>a</label>
<institution>Department of Pharmacy, Jilin Medical University</institution>
<city>Jilin</city>
<state>Jilin 132013</state>
<country>China</country>
<email>jinying2288@163.com</email>
<email>13630635312@163.com</email>
</aff><aff id="affb">
<label>b</label>
<institution>College of Pharmacy, Yanbian University</institution>
<city>Yanji</city>
<state>Jilin 133000</state>
<country>China</country>
</aff></contrib-group><author-notes><fn id="fn2"><label>&#x02021;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-05-21"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2025-05-15"><day>15</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>15</volume><issue>21</issue><fpage>17031</fpage><lpage>17035</lpage><history><date date-type="received" iso-8601-date="2025-03-07"><day>7</day><month>3</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-05-14"><day>14</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>This journal is &#x000a9; The Royal Society of Chemistry</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Royal Society of Chemistry</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense" start_date="2025-05-21">https://creativecommons.org/licenses/by/3.0/</ali:license_ref><license-p>This article is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution 3.0 Unported Licence</ext-link>. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.</license-p></license></permissions><abstract><p>An asymmetric synthesis of spiro[indoline-3,1&#x02032;-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] derivatives was first developed through an organocatalysed cascade Knoevenagel/Michael/cyclization reaction using a quinidine-derived squaramide. Under the optimized conditions, the three-component reaction of isatins, malononitrile (cyanoacetate) and phthalhydrazide yields the desired pyrazolophthalazinyl spirooxindoles in good yields (73&#x02013;90%) with up to &#x0003e;99% enantiomer excess (ee).</p></abstract><abstract abstract-type="toc"><p>A series of chiral spiro[indoline-3,1&#x02032;-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] derivatives with excellent enantioselectivity were obtained for the first time through an organocatalysed cascade reaction.<graphic xlink:href="d5ra01633a-ga.jpg" id="ga" position="float"/></p></abstract><funding-group><award-group><funding-source>
<institution-wrap><institution>Education Department of Jilin Province</institution><institution-id institution-id-type="doi">10.13039/501100010211</institution-id></institution-wrap>
</funding-source><award-id>JJKH20240595KJ</award-id></award-group></funding-group><counts><page-count count="5"/></counts><custom-meta-group><custom-meta><meta-name>pubstatus</meta-name><meta-value>Paginated Article</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>The pyrazole ring is a key moiety in numerous biologically active compounds and clinical drugs,<sup><xref rid="cit1" ref-type="bibr">1</xref></sup> such as Viagra, Celebrex, and Analginum (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Therefore, the synthesis of heterocyclic compounds containing the pyrazole ring is a research hotspot in the fields of organic synthesis and medicinal chemistry.</p><fig position="float" id="fig1"><label>Fig. 1</label><caption><title>Examples of biologically active drugs containing pyrazole ring.</title></caption><graphic xlink:href="d5ra01633a-f1" position="float"/></fig><p>On the other hand, heterocyclic fused phthalazines have been found to possess cytotoxic, antimicrobial, anticonvulsant, antifungal, anticancer, anti-inflammatory, and cardiotonic activities.<sup><xref rid="cit2" ref-type="bibr">2</xref></sup> They also exhibited potential as new luminescence materials or fluorescence probes.<sup><xref rid="cit3" ref-type="bibr">3</xref></sup></p><p>In addition, optically active spirooxindole derivatives have been extensively investigated because of their prominent activities and wide utility as synthetic intermediates for alkaloids and clinical drugs.<sup><xref rid="cit4" ref-type="bibr">4</xref></sup> The methods for synthesizing various spirooxindoles, including spiro[N-heterocycle-oxindoles], spiro[cycloalkane-oxindoles] and spiro[O-heterocycle-oxindoles] <italic toggle="yes">etc.</italic> have been well established.<sup><xref rid="cit5a" ref-type="bibr">5<italic toggle="yes">a</italic></xref></sup> Over the past few years, significant progress has been made in the stereoselective construction of spirooxindole.<sup><xref rid="cit5" ref-type="bibr">5</xref></sup></p><p>Based on the biological activity of pyrazole, phthalazine, and spiroindole skeleton, according to the splicing principle, chemists have considered combining these three parts into one molecule. At present, several methods have been developed for the synthesis of racemic spiro[indoline-3,1&#x02032;-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] derivatives.<sup><xref rid="cit6" ref-type="bibr">6</xref></sup> Zhang,<sup><xref rid="cit6a" ref-type="bibr">6<italic toggle="yes">a</italic></xref></sup> Shi<sup><xref rid="cit6b" ref-type="bibr">6<italic toggle="yes">b</italic></xref></sup> and Kefayati<sup><xref rid="cit6c" ref-type="bibr">6<italic toggle="yes">c</italic></xref></sup> groups reported one-pot three-component reaction catalyzed by nickel chloride, pyridine, or tetrabutylammonium fluoride (TBAF) respectively as shown in <xref rid="sch1" ref-type="fig">Scheme 1(a)</xref>. However, there are no reports on the synthesis of optically pure pyrazolophthalazinyl spirooxindoles.</p><fig position="float" id="sch1" fig-type="scheme"><label>Scheme 1</label><caption><title>Spiro[indoline-3,1&#x02032;-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine].</title></caption><graphic xlink:href="d5ra01633a-s1" position="float"/></fig><p>As well known, the development of synthetic methods to access optically active spiro-heterocycles would be of significance for drug discovery.<sup><xref rid="cit7" ref-type="bibr">7</xref></sup> So, we herein first reported the asymmetric Michael/cyclization cascade reaction of malononitrile (cyanoacetate), phthalhydrazide with a variety of the substituted isatins (N1, C4, C5, C6, C7 substituents) to construct spiro-heterocycles by using cinchona-squaramide catalyst (<xref rid="sch1" ref-type="fig">Scheme 1(b)</xref>). Bifunctional organocatalysts 1a&#x02013;1i including cinchona alkaloids and Takemoto's catalysts bearing (thio)urea or squaramide<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> have been applied in this cascade reaction as shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>.</p><fig position="float" id="fig2"><label>Fig. 2</label><caption><title>The structure of catalysts 1a&#x02013;1i.</title></caption><graphic xlink:href="d5ra01633a-f2" position="float"/></fig></sec><sec><title>Results and discussion</title><p>We initially screened the bifunctional catalysts in the Knoevenagel/Michael/cyclization reaction of isatin (2a), malononitrile (3a) and phthalhydrazide with DCM as a solvent in the presence of 10 mol% of catalysts 1a&#x02013;1i (<xref rid="tab1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><title>Asymmetric cascade reaction of isatin, malononitrile and phthalhydrazide catalyzed by 1a&#x02013;i<xref rid="tab1fna" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="6" rowspan="1">
<inline-graphic xlink:href="d5ra01633a-u1.jpg" id="ugr1"/>
</th></tr><tr><th rowspan="1" colspan="1">Entry</th><th rowspan="1" colspan="1">Cat.</th><th rowspan="1" colspan="1">Solvent</th><th rowspan="1" colspan="1">Cat. loading (mol%)</th><th rowspan="1" colspan="1">Yield<xref rid="tab1fnb" ref-type="table-fn">b</xref> (%)</th><th rowspan="1" colspan="1">%ee<xref rid="tab1fnc" ref-type="table-fn">c</xref><sup>,</sup><xref rid="tab1fnd" ref-type="table-fn">d</xref></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1a</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">6 (&#x02212;)</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1b</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">92 (+)</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">98 (&#x02212;)</td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1d</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">94 (+)</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">1e</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">79 (+)</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">1f</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">97 (+)</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">1g</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">94 (&#x02212;)</td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">1h</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">89 (&#x02212;)</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">1i</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">96 (+)</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">CHCl<sub>3</sub></td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">93</td></tr><tr><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">DCE</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">84</td><td rowspan="1" colspan="1">95</td></tr><tr><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">CH<sub>3</sub>CN</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">85</td></tr><tr><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">EA</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">51</td></tr><tr><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">EtOH</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">39</td></tr><tr><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">Et<sub>2</sub>O</td><td align="char" char="." rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">&#x02014;</td></tr><tr><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">1c</td><td rowspan="1" colspan="1">DCM</td><td align="char" char="." rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">79</td></tr></tbody></table><table-wrap-foot><fn id="tab1fna"><label>a</label><p>Reaction conditions: isatin 2a (0.1 mmol), malononitrile 3a (0.1 mmol), phthalhydrazide (0.1 mmol) and catalysts 1a&#x02013;1i in solvent (1.0 mL) at rt for 24 h.</p></fn><fn id="tab1fnb"><label>b</label><p>Isolated yield.</p></fn><fn id="tab1fnc"><label>c</label><p>Determined by HPLC analysis (Chiralpak OJ&#x02013;H).</p></fn><fn id="tab1fnd"><label>d</label><p>The sign in parentheses indicates the sign of the optical rotation.</p></fn></table-wrap-foot></table-wrap><p>As shown in <xref rid="tab1" ref-type="table">Table 1</xref>, catalysts 1a&#x02013;i smoothly catalyzed the reaction to provide the desired product in 75&#x02013;88% yields (entries 1&#x02013;9). Among them, quinidine-derived squaramide catalyst 1c was screened to be the optimal catalyst in terms of yield and enantioselectivity (98% ee, entry 3). In addition, Takemoto's catalyst 1f with a urea moiety and catalyst 1i bearing a squaramide moiety induced the reaction with excellent enantioselectivities (entries 6 and 9). By comparison, catalysts 1e and 1h with a thiourea moiety showed bad asymmetric induction to give decreased ee values (79% and 89%, entries 5 and 8).</p><p>Since stereoselectivity of up to 98% has been achieved under the current conditions, there is not much room for further improvement. However, we would like to investigate the effect of solvents on the stereoselectivity of the reaction, and whether lowering the loading of catalyst can maintain excellent enantioselectivity. The results showed that solvents have a significant impact on the catalytic performance of the catalyst. Among the 8 selected solvents, dichloromethane was screened as the optimal solvent for the yield and enantioselectivity (entry 3), and halogenated alkane as solvents were found to be suitable for this reaction to give 93% and 95% ees respectively (entries 10 and 11), while low enantioselectivities were obtained in ethyl acetate and EtOH (entries 13 and 14). Surprisingly, Et<sub>2</sub>O was used as solvent, the transformation did not occur even with prolonged the reaction time of 36 h (entry 15). Additionally, reducing the catalyst loading to 5 mol% led to an obvious decrease in enantioselectivity and yield (entry 16 <italic toggle="yes">vs.</italic> 3). Thus, the optimized conditions were determined to be DCM as the solvent with a 10 mol% loading of catalyst 1c at rt.</p><p>With the optimized conditions in hand, we explored the scope and general applicability of the protocol. A wide range of substituted isatins (N1, C4, C5, C6 and C7 substituents) and 2 types of electron-rich nucleophiles, including malononitrile and cyanoacetates, were evaluated as shown in <xref rid="tab2" ref-type="table">Table 2</xref>.</p><table-wrap position="float" id="tab2"><label>Table 2</label><caption><title>Scope of the enantioselective three-component Knoevenagel/Michael/cyclization<xref rid="tab2fna" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="6" rowspan="1">
<inline-graphic xlink:href="d5ra01633a-u2.jpg" id="ugr2"/>
</th></tr><tr><th rowspan="1" colspan="1">Entry</th><th rowspan="1" colspan="1">2 (<italic toggle="yes">R</italic><sup>1</sup>, <italic toggle="yes">R</italic><sup>2</sup>)</th><th rowspan="1" colspan="1">
<italic toggle="yes">R</italic>
<sup>3</sup>
</th><th rowspan="1" colspan="1">Product</th><th rowspan="1" colspan="1">Yield<xref rid="tab2fnb" ref-type="table-fn">b</xref> (%)</th><th rowspan="1" colspan="1">%ee<xref rid="tab2fnc" ref-type="table-fn">c</xref></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2a (H,H)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4a</td><td align="char" char="." rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">98</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2b (H, 4-Cl)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4b</td><td align="char" char="." rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">96</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">2c (H, 4-Br)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4c</td><td align="char" char="." rowspan="1" colspan="1">87</td><td rowspan="1" colspan="1">92</td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2d (H, 5-F)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4d</td><td align="char" char="." rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">98</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">2e (H, 5-Cl)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4e</td><td align="char" char="." rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">94</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">2f (H, 5-Br)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4f</td><td align="char" char="." rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">98</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">2g (H, 5-NO<sub>2</sub>)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4g</td><td align="char" char="." rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">93</td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">2h (H, 5-Me)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4h</td><td align="char" char="." rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">99</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">2i (H, 5-OMe)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4i</td><td align="char" char="." rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">96</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">2j (H, 6-Br)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4j</td><td align="char" char="." rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">97</td></tr><tr><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">2k (H, 7-F)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4k</td><td align="char" char="." rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">90</td></tr><tr><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">2l (H, 7-Cl)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4l</td><td align="char" char="." rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">91</td></tr><tr><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">2m (H, 7-Br)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4m</td><td align="char" char="." rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">98</td></tr><tr><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">2n (H, 7-Me)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4n</td><td align="char" char="." rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">95</td></tr><tr><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">2o (H, 7-NO<sub>2</sub>)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4o</td><td align="char" char="." rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">93</td></tr><tr><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2p (Me, H)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4p</td><td align="char" char="." rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">&#x0003e;99</td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">2q (Bn, H)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4q</td><td align="char" char="." rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">88</td></tr><tr><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">2r (Bn, 5-Cl)</td><td rowspan="1" colspan="1">CN</td><td rowspan="1" colspan="1">4r</td><td align="char" char="." rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">92</td></tr><tr><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">2a (H, H)</td><td rowspan="1" colspan="1">COOMe</td><td rowspan="1" colspan="1">4s</td><td align="char" char="." rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">91</td></tr><tr><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">2a (H, H)</td><td rowspan="1" colspan="1">COOEt</td><td rowspan="1" colspan="1">4t</td><td align="char" char="." rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">98</td></tr><tr><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">2f (H, 5-Br)</td><td rowspan="1" colspan="1">COOEt</td><td rowspan="1" colspan="1">4u</td><td align="char" char="." rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">99</td></tr><tr><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">2m (H, 7-Br)</td><td rowspan="1" colspan="1">COOEt</td><td rowspan="1" colspan="1">4v</td><td align="char" char="." rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">99</td></tr><tr><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">2p (Me, H)</td><td rowspan="1" colspan="1">COOEt</td><td rowspan="1" colspan="1">4w</td><td align="char" char="." rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">99</td></tr></tbody></table><table-wrap-foot><fn id="tab2fna"><label>a</label><p>Reaction conditions: isatins 2 (0.1 mmol), 3 (0.1 mmol), phthalhydrazide (0.1 mmol) and catalyst 1c (0.01 mmol) in DCM (1.0 mL) at rt for 24 h.</p></fn><fn id="tab2fnb"><label>b</label><p>Isolated yield.</p></fn><fn id="tab2fnc"><label>c</label><p>Determined by HPLC analysis (Chiralpak IA, AS, AD, Chiralcel OD, OJ).</p></fn></table-wrap-foot></table-wrap><p>All of the substrates reacted smoothly to give the corresponding products in 73&#x02013;90% yield with excellent ees (88&#x02013;&#x0003e;99%). Compared with <italic toggle="yes">N</italic>1-benzyl substituted isatin, no substitution or methyl substituted isatin as substrates were found to be better for the enantioselectivity (entries 1 and 16 <italic toggle="yes">vs.</italic> entry 17). To broaden the scope of substrates, cyanoacetates were applied instead of malononitrile in the reaction, and excellent ee values of 91&#x02013;99% were obtained (entries 19&#x02013;23). Notably, ethyl cyanoacetate as substrate was found to be better than methyl cyanoacetate for the enantioselectivity and yield of the reaction (entry 20 <italic toggle="yes">vs.</italic> entry 19). Therefore, the screened catalytic condition showed excellent general applicability for this three components cascade reaction.</p><p>The absolute configuration of spiro[indoline-3,10-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] products 4 were unambiguously assigned as <italic toggle="yes">S</italic> according to the X-ray crystal structure analysis of 4d (<xref rid="fig3" ref-type="fig">Fig. 3</xref>).</p><fig position="float" id="fig3"><label>Fig. 3</label><caption><title>X-ray crystal structure of <italic toggle="yes">S</italic>-4d (CCDC: <uri>2384066</uri>).<sup><xref rid="cit9" ref-type="bibr">9</xref></sup></title></caption><graphic xlink:href="d5ra01633a-f3" position="float"/></fig><p>On the basis of the absolute stereochemistry of 4d, a plausible mechanism for the formation of spirooxindole derivative 4d was proposed according to the literature (<xref rid="sch2" ref-type="fig">Scheme 2</xref>).<sup><xref rid="cit10" ref-type="bibr">10</xref></sup> Isatin (2a) first condenses with malononitrile to yield the isatylidene malononitrile (A), one cyanide group of which is fixed and activated by the neighboring two squaramide N&#x02013;H moieties through double H-bonding, while phthalhydrazide is activated by an interaction between the tertiaryamine moiety of 1c and the amino group of phthalhydrazide (B). Then, <italic toggle="yes">Si</italic>-face addition of the nucleophilic phthalhydrazide to the electron-deficient isatylidene malononitrile results in a Michael adduct intermediate (C), which in turn transfers to intermediate (D) through proton immigration. Next, the intramolecular nucleophilic addition of the amino group to the cyano group produces a cyclic imino carbanion (E), which is further transformed to the final (<italic toggle="yes">S</italic>)-4d through subsequent proton immigration and tautomerization (<xref rid="sch2" ref-type="fig">Scheme 2</xref>).</p><fig position="float" id="sch2" fig-type="scheme"><label>Scheme 2</label><caption><title>Proposed mechanism for the formation of <italic toggle="yes">S</italic>-4d.</title></caption><graphic xlink:href="d5ra01633a-s2" position="float"/></fig></sec><sec><title>Conclusions</title><p>In summary, we described the first enantioselective Knoevenagel/Michael/cyclization cascade reaction of isatins, malononitrile (or cyanoacetates) and phthalhydrazide to produce spiro[indoline-3,10-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] in high enantioselectivity (88&#x02013;&#x0003e;99% ees). Moreover, we used our optimized conditions to expand upon the substrate scope of this reaction.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The data supporting this article have been included as part of the ESI.<xref rid="fn1" ref-type="fn">&#x02020;</xref></p></sec><sec><title>Author contributions</title><p>L. Y. Song and Y. H. Sun are co-first authors; they contributed equally to this work. They performed the experiments, acquired the original data and cultivated the single crystal. R. B. An conducted instrumental analysis. L. M. Wang supervised the experiment, analyzed and checked all the data, provided funding supporting. Y. Jin designed the research plan, wrote the draft and revised manuscript. All authors have given approval to the final version of the manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts to declare.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="RA-015-D5RA01633A-s001" position="float" content-type="local-data"><label>RA-015-D5RA01633A-s001</label><media xlink:href="RA-015-D5RA01633A-s001.pdf" id="d67e1038" position="anchor"/></supplementary-material><supplementary-material id="RA-015-D5RA01633A-s002" position="float" content-type="local-data"><label>RA-015-D5RA01633A-s002</label><media xlink:href="RA-015-D5RA01633A-s002.cif" id="d67e1041" position="anchor"/></supplementary-material></sec></body><back><ack><p>This research was funded by Key Project of Medicine and Health of Jilin Province (No. 20250204067YY), the Department of Education of Jilin province (No. JJKH20240595KJ), Postgraduate Innovation Program Project of Jilin Medical University (title: Synthesis of chiral 10-hydroxyphenanthrene compounds and the study of its anti-tumor activity, 2023zyc02) and Students' Program for Innovation and Entrepreneurship Training (No. S202413706026).</p></ack><ref-list><title>References</title><ref id="cit1"><element-citation publication-type="journal" id="cit1a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Elguero</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Goya</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jagerovic</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>A. M. S.</given-names></name>
</person-group><article-title>Pyrazoles as drugs: facts and fantasies</article-title><source>Targets Heterocycl. Syst.</source><year>2002</year><volume>6</volume><fpage>52</fpage><lpage>98</lpage></element-citation><element-citation publication-type="journal" id="cit1b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>S. K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Reddy</surname><given-names>P. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rao</surname><given-names>K. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lohray</surname><given-names>B. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Misra</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rajjak</surname><given-names>S. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rao</surname><given-names>Y. K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Venkatewarlu</surname><given-names>A.</given-names></name>
</person-group><article-title>Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1, 5-diarylpyrazole class of COX-2 inhibitors</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2004</year><volume>14</volume><fpage>499</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">14698190</pub-id>
</element-citation></ref><ref id="cit2"><element-citation publication-type="journal" id="cit2a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Al'-Assar</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zelenin</surname><given-names>K. N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lesiovskaya</surname><given-names>E. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bezhan</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Chakchir</surname><given-names>B. A.</given-names></name>
</person-group><article-title>Synthesis and pharmacological activity of 1-hydroxy-, 1-amino-, and 1-hydrazino-substituted 2, 3-dihydro-1<italic toggle="yes">H</italic>-pyrazolo [1, 2-<italic toggle="yes">a</italic>] pyridazine-5, 8-diones and 2, 3-dihydro-1<italic toggle="yes">H</italic>-pyrazolo [1, 2-<italic toggle="yes">b</italic>] phthalazine-5, 10-diones</article-title><source>Pharm. Chem. J.</source><year>2002</year><volume>36</volume><fpage>598</fpage><lpage>603</lpage></element-citation><element-citation publication-type="journal" id="cit2b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Jain</surname><given-names>R. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Vederas</surname><given-names>J. C.</given-names></name>
</person-group><article-title>Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2004</year><volume>14</volume><fpage>3655</fpage><lpage>3658</lpage><pub-id pub-id-type="pmid">15203137</pub-id>
</element-citation><element-citation publication-type="journal" id="cit2c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Carling</surname><given-names>R. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>K. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Street</surname><given-names>L. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wild</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Isted</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Leeson</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>O'Conner</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>McKernan</surname><given-names>R. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Quirk</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cook</surname><given-names>S. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Atack</surname><given-names>J. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Waftord</surname><given-names>K. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>S. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dawson</surname><given-names>G. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ferris</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Castro</surname><given-names>J. L.</given-names></name>
</person-group><article-title>3-Phenyl-6-(2-pyridyl) methyloxy-1, 2, 4-triazolo [3, 4-<italic toggle="yes">a</italic>] phthalazines and analogues: high-affinity <italic toggle="yes">&#x003b3;</italic>-aminobutyric acid-A benzodiazepine receptor ligands with &#x003b1;2, &#x003b1;3, and &#x003b1;5-subtype binding selectivity over &#x003b1;1</article-title><source>J. Med. Chem.</source><year>2004</year><volume>47</volume><fpage>1807</fpage><lpage>1822</lpage><pub-id pub-id-type="pmid">15027873</pub-id>
</element-citation><element-citation publication-type="journal" id="cit2d"><label> (d) </label><person-group person-group-type="author">
<name><surname>Grasso</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>DeSarro</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Micale</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zappala</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Puia</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Baraldi</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Demicheli</surname><given-names>C.</given-names></name>
</person-group><article-title>Synthesis and anticonvulsant activity of novel and potent 6, 7-methylenedioxyphthalazin-1 (2 <italic toggle="yes">H</italic>)-ones</article-title><source>J. Med. Chem.</source><year>2000</year><volume>43</volume><fpage>2851</fpage><lpage>2859</lpage><pub-id pub-id-type="pmid">10956193</pub-id>
</element-citation><element-citation publication-type="journal" id="cit2e"><label> (e) </label><person-group person-group-type="author">
<name><surname>Rodriguez-Ciria</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sanz</surname><given-names>A. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yunta</surname><given-names>M. J. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gomez-Contreras</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Navarro</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sanchez-Moreno</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Boutaleb-Charki</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Osuna</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Castineiras</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pardo</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cano</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Campayo</surname><given-names>L.</given-names></name>
</person-group><source>Bioorg. Med. Chem.</source><year>2007</year><volume>15</volume><fpage>2081</fpage><lpage>2091</lpage><pub-id pub-id-type="pmid">17222558</pub-id>
</element-citation><element-citation publication-type="journal" id="cit2f"><label> (f) </label><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X. N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z. H.</given-names></name>
</person-group><article-title>Highly efficient three-component synthesis of 1<italic toggle="yes">H</italic>-indazolo [1, 2-<italic toggle="yes">b</italic>] phthalazinetrione derivatives catalyzed by heteropolyacids</article-title><source>Monatsh. Chem.</source><year>2010</year><volume>141</volume><fpage>425</fpage><lpage>430</lpage></element-citation><element-citation publication-type="journal" id="cit2g"><label> (g) </label><person-group person-group-type="author">
<name><surname>De</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Baltas</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lamoral-Theys</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bruyere</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kiss</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bedos-Belval</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Saffon</surname><given-names>N.</given-names></name>
</person-group><article-title>Synthesis and anticancer activity evaluation of 2 (4-alkoxyphenyl) cyclopropyl hydrazides and triazolo phthalazines</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>2537</fpage><lpage>2548</lpage><pub-id pub-id-type="pmid">20303278</pub-id>
</element-citation><element-citation publication-type="journal" id="cit2h"><label> (h) </label><person-group person-group-type="author">
<name><surname>Galisteo</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Navarro</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Campayo</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yunta</surname><given-names>M. J. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gomez-Contreras</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Villa-Pulgarin</surname><given-names>J. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sierra</surname><given-names>B. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mollinedo</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gonzalez</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Garcia-Espana</surname><given-names>E.</given-names></name>
</person-group><article-title>Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1, 4-Bis {3-[<italic toggle="yes">N</italic>-(4-chlorobenzo [g] phthalazin-1-yl) aminopropyl]} piperazine</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>5301</fpage><lpage>5309</lpage><pub-id pub-id-type="pmid">20538470</pub-id>
</element-citation></ref><ref id="cit3"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wan</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xin</surname><given-names>H. Q.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yue</surname><given-names>C. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pang</surname><given-names>L. L.</given-names></name>
</person-group><article-title>Synthesis and luminescence of 7-amino-2<italic toggle="yes">H</italic>-indazolo [2, 1-<italic toggle="yes">b</italic>] phthalazine-1, 6, 11 (13<italic toggle="yes">H</italic>)-triones catalyzed by silica sulfuric acid</article-title><source>Lett. Org. Chem.</source><year>2009</year><volume>6</volume><fpage>219</fpage><lpage>223</lpage></element-citation></ref><ref id="cit4"><element-citation publication-type="journal" id="cit4a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>R. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cox</surname><given-names>R. J.</given-names></name>
</person-group><article-title>Paraherquamides, brevianamides, and asperparalines: laboratory synthesis and biosynthesis. An interim report</article-title><source>Acc. Chem. Res.</source><year>2003</year><volume>36</volume><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">12589698</pub-id>
</element-citation><element-citation publication-type="journal" id="cit4b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>J. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liao</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>B.</given-names></name>
</person-group><article-title>The development of biologically important spirooxindoles as new antimicrobial agents</article-title><source>Curr. Med. Chem.</source><year>2018</year><volume>25</volume><fpage>2233</fpage><lpage>2244</lpage><pub-id pub-id-type="pmid">29189121</pub-id>
</element-citation><element-citation publication-type="journal" id="cit4c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>G. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Desta</surname><given-names>Z. Y.</given-names></name>
</person-group><article-title>Isatins as privileged molecules in design and synthesis of spiro-fused cyclic frameworks</article-title><source>Chem. Rev.</source><year>2012</year><volume>112</volume><fpage>6104</fpage><lpage>6155</lpage><pub-id pub-id-type="pmid">22950860</pub-id>
</element-citation><element-citation publication-type="journal" id="cit4d"><label> (d) </label><person-group person-group-type="author">
<name><surname>Panda</surname><given-names>S. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>R. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bachawala</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mohapatra</surname><given-names>P. P.</given-names></name>
</person-group><article-title>Spirooxindoles as potential pharmacophores</article-title><source>Mini-Rev. Med. Chem.</source><year>2017</year><volume>17</volume><fpage>1515</fpage><lpage>1536</lpage><pub-id pub-id-type="pmid">29056096</pub-id>
</element-citation></ref><ref id="cit5"><element-citation publication-type="journal" id="cit5a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cobob</surname><given-names>A. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Franz</surname><given-names>A. K.</given-names></name>
</person-group><article-title>Recent advances in organocatalytic asymmetric multicomponent cascade reactions for enantioselective synthesis of spirooxindoles</article-title><source>Org. Chem. Front.</source><year>2021</year><volume>8</volume><fpage>4315</fpage><lpage>4348</lpage></element-citation><element-citation publication-type="journal" id="cit5b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Pellissier</surname><given-names>H.</given-names></name>
</person-group><article-title>Recent developments in asymmetric organocatalytic domino reactions</article-title><source>Adv. Synth. Catal.</source><year>2012</year><volume>354</volume><fpage>237</fpage><lpage>294</lpage></element-citation><element-citation publication-type="journal" id="cit5c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ishihara</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Barbas</surname><given-names>C. F.</given-names></name>
</person-group><article-title>Organocatalytic asymmetric assembly reactions: synthesis of spirooxindoles <italic toggle="yes">via</italic> organocascade strategies</article-title><source>ACS Catal.</source><year>2014</year><volume>4</volume><fpage>743</fpage><lpage>762</lpage></element-citation><element-citation publication-type="journal" id="cit5d"><label> (d) </label><person-group person-group-type="author">
<name><surname>Santo</surname><given-names>M. M. M.</given-names></name>
</person-group><article-title>Recent advances in the synthesis of biologically active spirooxindoles</article-title><source>Tetrahedron</source><year>2014</year><volume>70</volume><fpage>9735</fpage><lpage>9757</lpage></element-citation><element-citation publication-type="journal" id="cit5e"><label> (e) </label><person-group person-group-type="author">
<name><surname>Chauhan</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mahajan</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kaya</surname><given-names>U.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hack</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Enders</surname><given-names>D.</given-names></name>
</person-group><article-title>Bifunctional amine-squaramides: powerful hydrogen-bonding organocatalysts for asymmetric domino/cascade reactions</article-title><source>Adv. Synth. Catal.</source><year>2015</year><volume>357</volume><fpage>253</fpage><lpage>281</lpage></element-citation><element-citation publication-type="journal" id="cit5f"><label> (f) </label><person-group person-group-type="author">
<name><surname>Ardkhean</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Caputo</surname><given-names>D. F. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Morrow</surname><given-names>S. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xiong</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>E. A.</given-names></name>
</person-group><article-title>Cascade polycyclizations in natural product synthesis</article-title><source>Chem. Soc. Rev.</source><year>2016</year><volume>45</volume><fpage>1557</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">26791791</pub-id>
</element-citation><element-citation publication-type="journal" id="cit5g"><label> (g) </label><person-group person-group-type="author">
<name><surname>Ziarani</surname><given-names>G. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moradi</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lashgari</surname><given-names>N.</given-names></name>
</person-group><article-title>Asymmetric synthesis of chiral oxindoles using isatin as starting material</article-title><source>Tetrahedron</source><year>2018</year><volume>74</volume><fpage>1323</fpage><lpage>1353</lpage></element-citation><element-citation publication-type="journal" id="cit5h"><label> (h) </label><person-group person-group-type="author">
<name><surname>Chanda</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>J. C. G.</given-names></name>
</person-group><article-title>Recent progress in organocatalytic asymmetric domino transformations</article-title><source>Adv. Synth. Catal.</source><year>2018</year><volume>360</volume><fpage>2</fpage><lpage>79</lpage></element-citation><element-citation publication-type="journal" id="cit5i"><label> (i) </label><person-group person-group-type="author">
<name><surname>Mei</surname><given-names>G. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>F.</given-names></name>
</person-group><article-title>Catalytic asymmetric synthesis of spirooxindoles: recent developments</article-title><source>Chem. Commun.</source><year>2018</year><volume>54</volume><fpage>6607</fpage><lpage>6621</lpage></element-citation><element-citation publication-type="journal" id="cit5j"><label> (j) </label><person-group person-group-type="author">
<name><surname>Konda</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jakkampudi</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Arman</surname><given-names>H. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>J. C. G.</given-names></name>
</person-group><article-title>Enantioselective synthesis of spiro [4<italic toggle="yes">H</italic>-pyran-3, 3&#x02032;-oxindole] derivatives catalyzed by cinchona alkaloid thioureas: Significant water effects on the enantioselectivity</article-title><source>Synth. Commun.</source><year>2019</year><volume>49</volume><fpage>2971</fpage><lpage>2982</lpage><pub-id pub-id-type="pmid">33012850</pub-id>
</element-citation><element-citation publication-type="journal" id="cit5k"><label> (k) </label><person-group person-group-type="author">
<name><surname>Tian</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>Z. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>Q. Q.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhan</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Han</surname><given-names>B.</given-names></name>
</person-group><article-title>Catalytic asymmetric [3+2] cycloaddition of pyrazolone-derived MBH carbonate: highly stereoselective construction of the bispiro-[pyrazolone-dihydropyrrole-oxindole] skeleton</article-title><source>Chem. Commun.</source><year>2022</year><volume>58</volume><fpage>5363</fpage><lpage>5366</lpage></element-citation><element-citation publication-type="journal" id="cit5l"><label> (l) </label><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mu</surname><given-names>H. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>Y. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W.</given-names></name>
</person-group><article-title>Asymmetric Synthesis of Spiro[4<italic toggle="yes">H</italic>-Chromene-3,3&#x02032;-oxindoles] <italic toggle="yes">via</italic> a Squaramide-Organocatalytic Three-Component Cascade Knoevenagel/Michael/Cyclization Sequence</article-title><source>Mol. Diversity</source><year>2025</year><volume>29</volume><fpage>293</fpage><lpage>302</lpage></element-citation></ref><ref id="cit6"><element-citation publication-type="journal" id="cit6a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X. N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y. X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z. H.</given-names></name>
</person-group><article-title>Nickel chloride-catalyzed one-pot three-component synthesis of pyrazolophthalazinyl spirooxindoles</article-title><source>Tetrahedron</source><year>2011</year><volume>67</volume><fpage>7426</fpage><lpage>7430</lpage></element-citation><element-citation publication-type="journal" id="cit6b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>D. Q.</given-names></name>
</person-group><article-title>Efficient One-Pot Synthesis of Spiro[indoline-3,10-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] Derivatives <italic toggle="yes">via</italic> Three-Component Reaction</article-title><source>J. Heterocycl. Chem.</source><year>2013</year><volume>50</volume><fpage>56</fpage><lpage>60</lpage></element-citation><element-citation publication-type="journal" id="cit6c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Kefayati</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Khandan</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tavancheh</surname><given-names>S.</given-names></name>
</person-group><article-title>Ultrasound-assisted synthesis of pyrazolo [1, 2-<italic toggle="yes">b</italic>] phthalazines and dihydrospiro [indoline-3, 1'-pyrazolo [1, 2-<italic toggle="yes">b</italic>] phthalazines] using TBAF as an efficient phase-transfer catalyst</article-title><source>Russ. J. Gen. Chem.</source><year>2015</year><volume>85</volume><fpage>1735</fpage><lpage>1740</lpage></element-citation><element-citation publication-type="journal" id="cit6d"><label> (d) </label><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J. X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>X. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>C. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zou</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>D. Q.</given-names></name>
</person-group><article-title>Ultrasound-Promoted One-Pot, Three-Component Synthesis of Spiro[indoline-3,1'-pyrazolo[1,2-<italic toggle="yes">b</italic>]phthalazine] Derivatives</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>8674</fpage><lpage>8686</lpage><pub-id pub-id-type="pmid">22825620</pub-id>
</element-citation><element-citation publication-type="journal" id="cit6e"><label> (e) </label><person-group person-group-type="author">
<name><surname>Rezaei</surname><given-names>S. J. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bide</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nabid</surname><given-names>M. R.</given-names></name>
</person-group><article-title>An efficient ultrasound-promoted one pot synthesis of spiroacenaphthylene pyrazolotriazole
and pyrazolophthalazine derivatives</article-title><source>Tetrahedron Lett.</source><year>2012</year><volume>53</volume><fpage>5123</fpage><lpage>5126</lpage></element-citation><element-citation publication-type="journal" id="cit6f"><label> (f) </label><person-group person-group-type="author">
<name><surname>Khazaei</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zolfigol</surname><given-names>M. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Karimitabar</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nikokar</surname><given-names>I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moosavi-Zare</surname><given-names>A. R.</given-names></name>
</person-group><article-title>N, 2-Dibromo-6-chloro-3, 4-dihydro-2 <italic toggle="yes">H</italic>-benzo [e] [1, 2, 4] thiadiazine-7-sulfonamide 1, 1-dioxide: An efficient and homogeneous catalyst for one-pot synthesis of 4 <italic toggle="yes">H</italic>-pyran, pyranopyrazole and pyrazolo [1, 2-<italic toggle="yes">b</italic>] phthalazine derivatives under aqueous media</article-title><source>RSC Adv.</source><year>2015</year><volume>5</volume><fpage>71402</fpage><lpage>71412</lpage></element-citation></ref><ref id="cit7"><element-citation publication-type="journal" id="cit7a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Badillo</surname><given-names>J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hanhan</surname><given-names>N. V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Franz</surname><given-names>A. K.</given-names></name>
</person-group><article-title>Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery</article-title><source>Curr. Opin. Drug Discovery Dev.</source><year>2010</year><volume>13</volume><fpage>758</fpage><lpage>776</lpage></element-citation><element-citation publication-type="journal" id="cit7b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J.</given-names></name>
</person-group><article-title>Catalytic asymmetric synthesis of oxindoles bearing a tetrasubstituted stereocenter at the C-3 position</article-title><source>Adv. Synth. Catal.</source><year>2010</year><volume>352</volume><fpage>1381</fpage><lpage>1407</lpage></element-citation><element-citation publication-type="journal" id="cit7c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>W. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>Z. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pei</surname><given-names>Q. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cun</surname><given-names>L. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>W. C.</given-names></name>
</person-group><article-title>Highly enantioselective construction of spiro [4<italic toggle="yes">H</italic>-pyran-3, 3&#x02032;-oxindoles] through a domino Knoevenagel/Michael/cyclization sequence catalyzed by cupreine</article-title><source>Org. Lett.</source><year>2010</year><volume>12</volume><fpage>3132</fpage><lpage>3135</lpage><pub-id pub-id-type="pmid">20545337</pub-id>
</element-citation><element-citation publication-type="journal" id="cit7d"><label> (d) </label><person-group person-group-type="author">
<name><surname>Trost</surname><given-names>B. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>M. K.</given-names></name>
</person-group><article-title>Asymmetric syntheses of oxindole and indole spirocyclic alkaloid natural products</article-title><source>Synthesis</source><year>2009</year><volume>18</volume><fpage>3003</fpage><lpage>3025</lpage></element-citation></ref><ref id="cit8"><element-citation publication-type="journal" id="cit8a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Okino</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hoashi</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Takemoto</surname><given-names>Y.</given-names></name>
</person-group><article-title>Enantioselective Michael Reaction of Malonates to Nitroolefins Catalyzed by Bifunctional Organocatalysts</article-title><source>J. Am. Chem. Soc.</source><year>2003</year><volume>125</volume><fpage>12672</fpage><lpage>12673</lpage><pub-id pub-id-type="pmid">14558791</pub-id>
</element-citation><element-citation publication-type="journal" id="cit8b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Malerich</surname><given-names>J. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hagihara</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rawal</surname><given-names>V. H.</given-names></name>
</person-group><article-title>Chiral Squaramide Derivatives are Excellent Hydrogen Bond Donor Catalysts</article-title><source>J. Am. Chem. Soc.</source><year>2008</year><volume>130</volume><fpage>14416</fpage><lpage>14417</lpage><pub-id pub-id-type="pmid">18847268</pub-id>
</element-citation></ref><ref id="cit9"><mixed-citation publication-type="other">CCDC <uri>2384066</uri> (<bold>4d</bold>) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge, available online: <uri xlink:href="https://www.ccdc.cam.ac.uk/structures/">https://www.ccdc.cam.ac.uk/structures/</uri></mixed-citation></ref><ref id="cit10"><element-citation publication-type="journal" id="cit10a"><label> (a) </label><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>X. X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>Y. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>Y. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kai</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>He</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X. Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y. Q.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>R.</given-names></name>
</person-group><article-title>Core Scaffold-Inspired Concise Synthesis of Chiral Spirooxindole Pyranopyrimidines with Broad-Spectrum Anticancer Potency</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>15807</fpage><lpage>15826</lpage><pub-id pub-id-type="pmid">26334263</pub-id>
</element-citation><element-citation publication-type="journal" id="cit10b"><label> (b) </label><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>C. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>He</surname><given-names>X. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Du</surname><given-names>W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y. C.</given-names></name>
</person-group><article-title>Asymmetric Direct Remote Michael Addition Reactions of Allyl Furfurals <italic toggle="yes">via</italic> Dearomative Trienamine and Tetraenamine Catalysis</article-title><source>Asian J. Org. Chem.</source><year>2019</year><volume>8</volume><fpage>1037</fpage><lpage>1040</lpage></element-citation><element-citation publication-type="journal" id="cit10c"><label> (c) </label><person-group person-group-type="author">
<name><surname>Balha</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mondal</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pan</surname><given-names>S. C.</given-names></name>
</person-group><article-title>Organocatalytic asymmetric synthesis of dihydrofuran-spirooxindoles from benzylidene malononitriles and dioxindoles</article-title><source>Org. Biomol. Chem.</source><year>2019</year><volume>17</volume><fpage>6557</fpage><lpage>6561</lpage><pub-id pub-id-type="pmid">31241100</pub-id>
</element-citation></ref></ref-list></back></article>